L-Glu(OAll)OAll | 45172-25-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: L-Glu(OAll)OAll
• 英文别名: diallyl L-glutamate；bis(prop-2-enyl) (2S)-2-aminopentanedioate
• CAS: 45172-25-6
• 化学式: C₁₁H₁₇NO₄
• 分子量: 227.26
• InChiKey: JQTAOTLIRWYSFQ-VIFPVBQESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  16
• 可旋转键数：
  10
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  78.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  L-Glu(OAll)OAll 在 四(三苯基膦)钯 、 potassium 2-ethylhexanoate 、 三苯基膦 作用下， 以 二氯甲烷 、 乙酸乙酯 为溶剂， 反应 44.0h， 生成 O^1.4-ethyl dihydrogen N^2.1,N^6.1-di-Cbz-L-lysylglycyl-α-L-aspartyl-L-glutamate
  参考文献：
  名称：

  Gill, Iqbal; López-Fandiño, Rosina; Vulfson, Evgeny, Journal of the American Chemical Society, 1995, vol. 117, # 23, p. 6175 - 6177

  摘要：

  DOI：

文献信息

• BLOCK COPOLYMERS FOR STABLE MICELLES
  申请人：Intezyne Technologies, Inc.

  公开号：US20130280306A1

  公开（公告）日：2013-10-24

  The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.

  本发明涉及聚合物化学领域，更具体地说是涉及多区块共聚物以及包含相同的多区块共聚物胶束。本发明的组合物适用于药物输送应用。
• HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS
  申请人：SILL Kevin N.

  公开号：US20080274173A1

  公开（公告）日：2008-11-06

  The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same.

  本发明涉及聚合物化学领域，更具体地说是涉及多嵌段共聚物以及包含该共聚物的胶束。
• [EN] POLYMER MICELLES CONTAINING ANTHRACYLINES FOR THE TREATMENT OF CANCER<br/>[FR] MICELLES POLYMÈRES CONTENANT DES ANTHRACYCLINES UTILISABLES À DES FINS DE TRAITEMENT DU CANCER
  申请人：INTEZYNE TECHNOLOGIES INC

  公开号：WO2010127271A1

  公开（公告）日：2010-11-04

  The present invention provides micelles having an anthracycline encapsulated therein, the micelles comprising a multiblock copolymer. The invention further provides methods of preparing and using said micelles, and compositions thereof.

  本发明提供了包含蒽环类药物的胶束，所述胶束包括多嵌段共聚物。该发明还提供了制备和使用所述胶束以及其组合物的方法。
• Hypophosphorous Acid Derivatives and their Therapeutical Applications
  申请人：Acher Francine

  公开号：US20090170813A1

  公开（公告）日：2009-07-02

  Hypophosphorous acid derivatives having Formula (I) wherein .M is a [C(R3,R4)]n1-C(E,COOR1,N(H,Z)) group, or an optionally substituted Ar—CH(COOR1,N(H,Z)) group, or an a, β, or a β, g-cyclic amino acid; .R 1 is H or R, R being an hydroxy or a carboxy protecting group; .Z is H or an amino protecting group R′, benzyl oxycarbonyl, benzyl or benzyl substituted; .E is H or a C1-C3 alkyl, aryl, an hydrophobic group; .R 2 is selected in the group comprising: D-CH(R 6 )—C—(R 7 ,R 8 ), (R 11 ,R 12 )CH—C(R 9 ,R 10 ), D-CH(OH), D-[C(R 13 ,R 14 )] n3 —, C[(R 15 ,R 16 ,R 17 )] n4 , D-CH 2 , (R 18 )CH═C(R 19 ), D-(M 1 ) n6 —CO, Formula (II), PO(OH) 2 —CH 2 or (PO(OH) 2 —CH 2 ), (COOH—CH 2 )—CH 2 , with -D=H, OH, OR, (CH 2 ) n2 OH, (CH 2 ) n1 OR, COOH, COOR, (CH 2 ) n2 COOH, (CH 2 ) n1 COOR, SR, S(OR), SO 2 R, NO 2 , heteroaryl, C 1 -C 3 alkyl, cycloalkyl, heterocycloalkyl, (CH 2 ) n2 -alkyl, (COOH,NH 2 )—(CH 2 ) u1 -cyclopropyl-(CH 2 ) u2 —, CO—NH-alkyl, Ar, (CH 2 ) n2 —Ar, CO—NH—Ar; —R 3 to R 19 being H, OH, OR, (CH 2 ) n2 OH, (CH 2 ) n1 OR, COOH, COOR, (CH 2 ) n2 COOH, (CH 2 ) n1 COOR, C 1 -C 3 alkyl, cycloalkyl, (CH 2 )n1-alkyl, aryl, (CH 2 )n1-aryl, halogen, CF 3 , SO 3 H, (CH 2 ) x PO 3 H 2 , with x=0, 1 or 2, B(OH) 2 , Formula (III), NO 2 , SO 2 NH 2 , SO 2 NHR; SR, S(O)R, SO 2 R, benzyl; -M 1 is an alkylene or arylene group; -n1=1, 2 or 3, n2=1, 2 or 3, n3=0, 1, 2 or 3 and n4=1, 2 or 3, n5=1, 2 or 3, n6=0 or 1, u1 and u2, identical or different=0, 1 or 2, with the proviso that Formula (I) does not represent the racemic (3R,S) and the enantiomeric form (3R) of 3 amino,3-carboxy-propyl-2′-carboxy-ethylphosphinic acid; 3 amino,3-carboxy-propyl-4′carboxy,2′carboxy-butanoylphosphinic acid; 3 amino,3-carboxy-propyl-2′carboxy-butanoylphosphinic acid; 3 amino,3-carboxy-propyl-3′amino, 3′carboxy-propylylphosphinic acid; and 3 amino,3-carboxypropyl-7′amino-2′, 7′-dicarboxyheptylphosphinic acid, said hypophosphorous acid derivatives being diasteroisomers or enantiomers. Application as drugs.

  含有Formula (I)的次磷酸衍生物，其中.M是[C(R3,R4)]n1-C(E,COOR1,N(H,Z))基团，或者是一个可选择取代的Ar—CH(COOR1,N(H,Z))基团，或者是α，β或αβ，γ-环氨基酸；.R1是H或R，R是一个羟基或羧基保护基团；.Z是H或氨基保护基团R′，苄氧羰基，苄基或苄基取代；.E是H或C1-C3烷基，芳基，疏水基团；.R2是从以下群体中选择的：D-CH(R6)—C—(R7,R8)，(R11,R12)CH—C(R9,R10)，D-CH(OH)，D-[C(R13,R14)]n3—，C[(R15,R16,R17)]n4，D-CH2，(R18)CH═C(R19)，D-(M1)n6—CO，Formula (II)，PO(OH)2— 或(PO(OH)2— )，(COOH— )— ，其中-D=H，OH，OR，( )n2OH，( )n1OR，COOH，COOR，( )n2COOH，( )n1COOR，SR，S(OR)，SO2R，NO2，杂环芳基，C1-C3烷基，环烷基，杂环烷基，( )n2-烷基，(COOH,NH2)—( )u1-环丙基-( )u2—，CO—NH-烷基，Ar，( )n2—Ar，CO—NH—Ar；—R3到R19为H，OH，OR，( )n2OH，( )n1OR，COOH，COOR，( )n2COOH，( )n1COOR，C1-C3烷基，环烷基，( )n1-烷基，芳基，( )n1-芳基，卤素，CF3，SO3H，( )xPO3H2，其中x=0，1或2，B(OH)2，Formula (III)， ，SO2NH2，SO2NHR；SR，S(O)R，SO2R，苄基；-M1是一个烷基或芳基基团；-n1=1，2或3，n2=1，2或3，n3=0，1，2或3，n4=1，2或3，n5=1，2或3，n6=0或1，u1和u2，相同或不同=0，1或2，但Formula (I)不代表3-氨基，3-羧基-丙基-2′-羧基-乙磷酸的消旋体(3R,S)和对映体形式(3R)；3-氨基，3-羧基-丙基-4′羧基，2′羧基-丁酰磷酸；3-氨基，3-羧基-丙基-2′羧基-丁酰磷酸；3-氨基，3-羧基-丙基-3′氨基，3′羧基-丙基磷酸；和3-氨基，3-羧基丙基-7′氨基-2′，7′-二羧基庚基磷酸，所述的次磷酸衍生物为二对映异构体或对映体。用作药物的应用。
• Easy Preparation of Bioactive Peptides from the Novel<i>N</i>^α-Trifluoroethyl Amino Acids
  作者：Darryl D. DesMarteau、Vittorio Montanari

  DOI：10.1246/cl.2000.1052

  日期：2000.9

  Nα-Trifluoroethyl amino acids have been prepared for the first time and unexpectedly found to behave as conventionally N-protected amino acids. Novel unnatural peptides are easily prepared in high yields without racemization. The observed chemistry results from steric factors as well as from the acidity of the CF3CH2NH group, according to comparative experiments. Of ten dipeptides that were tested

  首次制备了 Nα-三氟乙基氨基酸，并出人意料地发现其行为与常规 N-保护的氨基酸相同。无需外消旋化即可高产率地轻松制备新型非天然肽。根据比较实验，观察到的化学反应来自空间因素以及 CF3CH2NH 基团的酸度。在测试抗肿瘤活性的十种二肽中，CF3CH2–L-Tyr–L-Ile–OtBu 是最有活性的。